Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Killander

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|September 22, 1984
Successful treatment of pure red-cell aplasia with cyclosporinT H Tötterman, J Nisell, A Killander, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1985
CHOP vs MEV for the treatment of non-Hodgkin's lymphoma of unfavourable histopathology: a randomized clinical trialH Hagberg, M Björkholm, B Glimelius, et al.
Scandinavian Journal of Haematology|July 1, 1984
Biochemical markers in non-Hodgkin's lymphoma stages III and IV and prognosis: a multivariate analysisH Hagberg, B Glimelius, S Gronowitz, et al.
Scandinavian Journal of Haematology|February 1, 1985
Treatment of therapy-resistant Sézary syndrome with Cyclosporin-A: suppression of pruritus, leukaemic T cell activation markers and tumour massT H Tötterman, A Scheynius, A Killander, et al.
Vox Sanguinis|January 1, 1980
Serum ferritin in the regulation of iron therapy in blood donorsG Birgegård, C Högman, A Johansson, et al.
Scandinavian Journal of Haematology|October 1, 1978
Serum ferritin during infection. A longitudinal studyG Birgegård, R Hällgren, A Killander, et al.
Scandinavian Journal of Haematology|October 1, 1977
Serum ferritin and erythrocyte 2,3-DPG during quantitated phlebotomy and iron treatmentG Birgegård, C Högman, A Killander, et al.
European Journal of Haematology|February 1, 1989
Treatment of pure red-cell aplasia and aplastic anaemia with ciclosporin: long-term clinical effectsT H Tötterman, M Höglund, M Bengtsson, et al.
British Journal of Haematology|May 1, 1988
Biochemical markers in multiple myeloma: a multivariate analysisB Simonsson, C F Källander, G Brenning, et al.
British Journal of Haematology|October 1, 1985
Evaluation of serum deoxythymidine kinase as a marker in multiple myelomaB Simonsson, C F Källander, G Brenning, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|September 22, 1984
Successful treatment of pure red-cell aplasia with cyclosporinT H Tötterman, J Nisell, A Killander, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1985
CHOP vs MEV for the treatment of non-Hodgkin's lymphoma of unfavourable histopathology: a randomized clinical trialH Hagberg, M Björkholm, B Glimelius, et al.
Scandinavian Journal of Haematology|July 1, 1984
Biochemical markers in non-Hodgkin's lymphoma stages III and IV and prognosis: a multivariate analysisH Hagberg, B Glimelius, S Gronowitz, et al.
Scandinavian Journal of Haematology|February 1, 1985
Treatment of therapy-resistant Sézary syndrome with Cyclosporin-A: suppression of pruritus, leukaemic T cell activation markers and tumour massT H Tötterman, A Scheynius, A Killander, et al.
Vox Sanguinis|January 1, 1980
Serum ferritin in the regulation of iron therapy in blood donorsG Birgegård, C Högman, A Johansson, et al.
Scandinavian Journal of Haematology|October 1, 1978
Serum ferritin during infection. A longitudinal studyG Birgegård, R Hällgren, A Killander, et al.
Scandinavian Journal of Haematology|October 1, 1977
Serum ferritin and erythrocyte 2,3-DPG during quantitated phlebotomy and iron treatmentG Birgegård, C Högman, A Killander, et al.
European Journal of Haematology|February 1, 1989
Treatment of pure red-cell aplasia and aplastic anaemia with ciclosporin: long-term clinical effectsT H Tötterman, M Höglund, M Bengtsson, et al.
British Journal of Haematology|May 1, 1988
Biochemical markers in multiple myeloma: a multivariate analysisB Simonsson, C F Källander, G Brenning, et al.
British Journal of Haematology|October 1, 1985
Evaluation of serum deoxythymidine kinase as a marker in multiple myelomaB Simonsson, C F Källander, G Brenning, et al.
Pageof 7